Intensification of Early-Phase Therapy to Diminish the Prognostic Effect of Myeloid Antigen Expression in Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia: A Report from the JPLSG MLL-10 Trial.
Intensification of Early-Phase Therapy to Diminish the Prognostic Effect of Myeloid Antigen Expression in Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia: A Report from the JPLSG MLL-10 Trial.
复制标题
强化早期治疗以降低 KMT2A 重排急性淋巴细胞白血病婴儿骨髓抗原表达的预后影响：JPLSG MLL-10 试验报告。
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Daisuke
中科院分区：
文献类型：
--
作者：
Yuki Arakawa;Takashi Ishihara;Takako Miyamura;Takao Deguchi;Masashi Sanada;Toshinori Hori;Tomomi Yamada;MD;Yuki Aoki;Sae Ishimaru;Takayuki Takachi;Mio Yano;Shinya Sasaki;Akiko M Saito;Atsushi Manabe;Keizo Horibe;Toshihiko Imamura;Daisuke
